Sera Prognostics Inc-A

Penny Stocks Biotech Stocks Healthcare Stocks

$2.01

-0.02 (-0.99%)

As of Apr 1, 3:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,586.1% upside

Low Target $29.33

Average Target $33.89

High Target $54.04

Current Price $2.01

Current
$2.01

Target
$33.89

$29.33 $33.89 avg $54.04

Scenario Analysis

Bear Case

$29.33

1,359.2%

Low target

Base Case

$33.89

+1,586.1%

Avg target

Bull Case

$54.04

+2,588.6%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$4.09

-50.9% from high

52-Week Low

$1.37

+46.7% from low

Target vs 52W High

$33.89

+728.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%